PubRank

Kenji Takabayashi

Author PubWeight™ 24.31‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis. Gastroenterology 2004 6.47
2 Immunostimulatory DNA ameliorates experimental and spontaneous murine colitis. Gastroenterology 2002 2.19
3 A subset of Toll-like receptor ligands induces cross-presentation by bone marrow-derived dendritic cells. J Immunol 2003 2.04
4 Inhibition of experimental asthma by indoleamine 2,3-dioxygenase. J Clin Invest 2004 1.98
5 IFN-alpha beta promote priming of antigen-specific CD8+ and CD4+ T lymphocytes by immunostimulatory DNA-based vaccines. J Immunol 2002 1.30
6 Immunotherapeutic activity of a conjugate of a Toll-like receptor 7 ligand. Proc Natl Acad Sci U S A 2007 1.28
7 Immunostimulatory DNA sequences influence the course of adjuvant arthritis. J Immunol 2002 1.03
8 Immunostimulatory oligonucleotides inhibit colonic proinflammatory cytokine production in ulcerative colitis. Inflamm Bowel Dis 2006 1.00
9 Antigen-immunostimulatory oligonucleotide conjugates: mechanisms and applications. Immunol Rev 2004 0.88
10 Suppression of allergic response by CpG motif oligodeoxynucleotide-house-dust mite conjugate in animal model of allergic rhinitis. Am J Rhinol 2006 0.87
11 Allergen-immunostimulatory oligodeoxynucleotide conjugate: a novel allergoid for immunotherapy. Curr Opin Allergy Clin Immunol 2002 0.85
12 Liposomal immunostimulatory DNA sequence (ISS-ODN): an efficient parenteral and mucosal adjuvant for influenza and hepatitis B vaccines. Vaccine 2002 0.84
13 Allergen-independent immunostimulatory sequence oligodeoxynucleotide therapy attenuates experimental allergic rhinitis. Immunology 2004 0.83
14 The therapeutic potential of antigen-oligonucleotide conjugates. Ann N Y Acad Sci 2003 0.81
15 Induction and inhibition of the Th2 phenotype spread: implications for childhood asthma. J Immunol 2005 0.78
16 Optimized conjugation ratios lead to allergen immunostimulatory oligodeoxynucleotide conjugates with retained immunogenicity and minimal anaphylactogenicity. J Allergy Clin Immunol 2002 0.78
17 DNA-based vaccines for allergic disease. Expert Rev Vaccines 2002 0.76
18 Retraction: DNA-PKcs is required for activation of innate immunity by immunostimulatory DNA. Cell 2009 0.75